Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy (Q65358479)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy |
clinical trial |
Statements
A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy (English)
0 references
October 2014
0 references
23 March 2018
0 references
76
0 references
18 year
0 references
70 year
0 references